Lack Of Standardization, Evidence Hinders Wireless Patient Monitoring

Although venture capitalists recognize the potential for long-term returns from bringing "disruptive" wireless patient monitoring (WPM) technologies to market, the lack of standards in interoperability may delay the scaling up of these technologies, says a new report from research firm Frost & Sullivan.

"The lack of standardization of wireless data interfacing sensors and monitoring devices needs attention as soon as possible," states the report. "Standardization among the different entities in the WPM market is necessary to improve interoperability among devices, choice of system assembly, and other related services."

Moreover, WPM companies need to back their technology with "strong evidence-based clinical trials" and "routine adoption of outcome measures as part of patient assessment," argues the report.  This is critical because "investors need documented proof before investing," asserts the report...